60 DEGREES PHARMACEUTICALS, INC. Debt Instrument, Increase, Accrued Interest
60 DEGREES PHARMACEUTICALS, INC. (SXTP) reported Debt Instrument, Increase, Accrued Interest of $659.31 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-25.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentIncreaseAccruedInterest · last filed 2023-08-25
- 60 DEGREES PHARMACEUTICALS, INC. debt instrument, increase, accrued interest for the quarter ending 2023-06-30 was $659.31K.
- 60 DEGREES PHARMACEUTICALS, INC. debt instrument, increase, accrued interest for the quarter ending 2023-03-31 was $634.24K.
| Period end | Debt Instrument, Increase, Accrued Interest 3 month | Debt Instrument, Increase, Accrued Interest 6 month |
|---|---|---|
| 2023-06-30 | $659.31K 10-Q · filed 2023-08-25 | $1.29M derived: sum of 2 quarters · filed 2023-08-25 |
| 2023-03-31 | $634.24K 10-Q · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |